Altis Biologics (Pty) Ltd is a company specializing in the research and development of osteogenic biomaterials for use in skeletal regeneration therapies in man. The technological basis underlying the Altis Osteogenic Matrix are the Bone Morphogenetic Proteins (BMPs), a family of growth factors capable of inducing new bone formation commencing within days of implantation into human patients.

Case Study- Alveolar Ridge Regeneration Following Osteotomy Successful alveolar ridge regeneration in this patient obser ...  read more Altis Osteogenic Bone Matrix in patients with traumatic long bone defects: a phase I, open label, non-randomized, study over 3 months. Background Altis Osteogenic Bone Matrix (OBM) is a xenogen ...  read more

Altis Biologics secures... 2003- Altis Biologics secures a management contract for the start-up and running of the Centre for Tissue Engineering (CTE)...  read more Altis Biologics Awards license... 2004- Altis Biologics awards a license agreement to Osteogenix (Pty) Ltd for Southern Africa for the manufacture  read more